EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Successful Application of the Mast Cell Activation Test in Immediate Hypersensitivity to Amoxicillin

Jose A Céspedes iD, Clara Lebrón-Martín, Lucía Vallecillos-Azor, Pablo Torres, Amene Tesfaye Ayane, Gádor Bogas iD, María Salas iD, Adriana Ariza, María Isabel Montañez, María José Torres iD, Carlos José Aranda iD, Cristobalina Mayorga iD

Allergy · 2026-08 · 81 (8) · 2910-2922

DOI: 10.1111/all.70267 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Allergy, online erschienen am 19.02.2026. Verfasst von Jose A Céspedes und 11 weiteren Autor:innen. Beteiligte Einrichtung: Allergy Research Group, IBIMA Plataforma BIONAND, Málaga, Spain. Hauptthemen laut MEDLINE: Amoxicillin, Drug Hypersensitivity, Hypersensitivity, Immediate, Mast Cells. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Consejería de Conocimiento, Investigación y Universidad, Junta de Andalucía, Instituto de Salud Carlos III.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Immediate drug allergic reactions (IDAR) to betalactams are frequent, yet mislabelling remains common and negatively impacts clinical decisions. Conventional diagnostics such as STs and drug provocation are effective but limited by time, risk, and contraindications in severe cases. In vitro alternatives—sIgEquantification and basophil activation tests (BAT)—offer safer options, although performance may be affected by biological variability and suboptimal sensitivity with an important drawback for the latter in patients with non‐releaser basophils. This study aimed to evaluate a mast cell activation test (MAT) based on human CD34 + ‐derived mast cells (dMCs) for IDAR diagnosis to amoxicillin (AX) using both free AX and dendrimeric amoxicilloyl conjugates (G4/G5‐AXO).

Methods

CD34 + cells were cultured for 10–12 weeks to generate dMCs. After passive sensitization with sera from AX‐allergic patients ( N = 28) or tolerant controls ( N = 11), dMCs were stimulated with free AX, G4‐AXO, or G5‐AXO. Activation was quantified by CD63 expression via flow cytometry. Diagnostic performance was compared with BAT and sIgE determination by ImmunoCAP.

Results

MAT with free AX achieved 53.57% sensitivity, G4/G5‐AXO reached 46.43%, and all methods maintained 100% specificity. Combining results with AX or dendrimeric stimuli increased sensitivity to 75% while preserving specificity. Importantly, MAT identified positive cases among BAT non‐releasers and patients with undetectable sIgE.

Conclusions

Under optimized conditions, MAT using dMCs and different AX determinants reached 75% sensitivity and 100% specificity. The complementary use of free AX and dendrimeric conjugates expands detection across heterogeneous IgE reactivity profiles from AX‐allergic patients, reinforcing the diagnostic value of advanced cellular models and engineered allergens.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AmoxicillinDrug HypersensitivityHypersensitivity, ImmediateMast CellsHumansFemaleMaleAdultImmunoglobulin ESensitivity and SpecificityMiddle AgedAntigens, CD34Young Adult

Stichwörter der Autor:innen

IgEbasophil activation testdrug allergyin vitro testmast cell activation test

Substanzen

AmoxicillinImmunoglobulin EAntigens, CD34

Autor:innen und Institutionen

  • Allergy Research Group, IBIMA Plataforma BIONAND, Málaga, Spain.
  • Department of Medicine and Dermatology, Faculty of Medicine, Universidad de Málaga, Málaga, Spain.
  • Department of Organic Chemistry, Faculty of Science, Universidad de Málaga, Málaga, Spain.
  • Allergy Unit, Hospital Regional Universitario de Málaga, Málaga, Spain.

ORCID-Profile: Jose A Céspedes, Gádor Bogas, María Salas, María José Torres, Carlos José Aranda, Cristobalina Mayorga

Förderung

  • Consejería de Conocimiento, Investigación y Universidad, Junta de Andalucía
  • Instituto de Salud Carlos III

Zitieren

APA

Céspedes, J. A., Lebrón-Martín, C., Vallecillos-Azor, L., Torres, P., Ayane, A. T., Bogas, G., Salas, M., Ariza, A., Montañez, M. I., Torres, M. J., Aranda, C. J., & Mayorga, C. (2026). Successful Application of the Mast Cell Activation Test in Immediate Hypersensitivity to Amoxicillin. Allergy, 81(8), 2910-2922. https://doi.org/10.1111/all.70267

Vancouver

Céspedes JA, Lebrón-Martín C, Vallecillos-Azor L, Torres P, Ayane AT, Bogas G, et al. Successful Application of the Mast Cell Activation Test in Immediate Hypersensitivity to Amoxicillin. Allergy. 2026;81(8):2910-2922. doi:10.1111/all.70267

BibTeX
@article{Cspedes2026,
  author = {Céspedes, Jose A and Lebrón-Martín, Clara and Vallecillos-Azor, Lucía and Torres, Pablo and Ayane, Amene Tesfaye and Bogas, Gádor and Salas, María and Ariza, Adriana and Montañez, María Isabel and Torres, María José and Aranda, Carlos José and Mayorga, Cristobalina},
  title = {Successful Application of the Mast Cell Activation Test in Immediate Hypersensitivity to Amoxicillin},
  journal = {Allergy},
  year = {2026},
  volume = {81},
  number = {8},
  pages = {2910--2922},
  doi = {10.1111/all.70267}
}
Kostenlos starten →